Overview

The Dysautonomia Research Institute, founded by Dr. Ramesh Adiraju in 2005, is a clinical research and innovation center focused on advancing treatment protocols for dysautonomia and complex cardiovascular conditions.

Dr. Ramesh Adiraju, MD, FACC

Co-Founder & Chief Medical Officer, Autonomic Health
Founder, Dysautonomia Research Institute

Dr. Ramesh Adiraju is a world-leading physician in autonomic medicine, with over 20 years of experience advancing the diagnosis and treatment of dysautonomia and complex chronic diseases. He has pioneered clinical protocols that restore autonomic function and improve outcomes across conditions that are often difficult to manage using traditional approaches.

Autonomic Medicine & Dysautonomia Leadership

Dr. Adiraju founded the Dysautonomia Research Institute and has developed novel assessment and treatment protocols for autonomic dysfunction, focusing on restoring balance in the autonomic nervous system.

His work has been applied to a wide range of complex, multi-system conditions, including:

• Type II Diabetes
• Metabolic Syndrome
• Systemic inflammation with vasculopathy
• Postural Orthostatic Tachycardia Syndrome (POTS)
• Long COVID
• Attention deficit disorder/hyperactive disorder (ADD/ADHD)
• Syncope
• Chronic Fatigue Syndrome (CFS)
• Fibromyalgia
• Erythromelalgia

He has also extended autonomic-based approaches into broader disease areas, including:

• Type II diabetes
• Vascular endothelial dysfunction

His research has been published in peer-reviewed journals, including:

• Dysautonomia, Type II Diabetes and Vasculopathy (Elsevier, 2016)
• Dysautonomia: A Novel Approach to Understanding Vasculitis and Type II Diabetes (Journal of Rheumatology and Arthritis, 2017)

Dr. Adiraju has developed a novel autonomic neurohormonal modulation framework, enabling root-cause treatment of chronic conditions by regulating the body’s control systems rather than managing symptoms alone.

Clinical Innovation & Protocol Development

At the Dysautonomia Research Institute, Dr. Adiraju has successfully implemented autonomic-based treatment protocols in complex cardiometabolic conditions, including:

• Chronic congestive heart failure
• Cardiomyopathy

His protocols have reversed severe left ventricular dysfunction in nearly 100 patients, often avoiding the need for high-risk and expensive device therapies such as defibrillators.

He has also developed:

• Advanced autonomic modulation programs integrated with hemodynamic support
• Novel treatment frameworks linking autonomic dysfunction to systemic disease

These approaches form the clinical foundation for modern autonomic care and directly inform Autonomic Health’s CloudANS platform.

Cardiology & Interventional Background (Selective Highlights)

Dr. Adiraju is a board-certified interventional cardiologist and endovascular specialist with over three decades of clinical experience.

• Completed medical education at Kasturba Gandhi Medical College, Mangalore University, India (one of the oldest and most prestigious medical colleges in India)
• Residency in Internal Medicine at UPMC Shadyside Hospital, Pittsburgh
• Fellowship in Interventional Cardiology at Lankenau Hospital (Main Line Health), Philadelphia

He has performed:

• 6,000+ coronary interventions
• 2,000+ peripheral and endovascular procedures
• 500+ complex high-risk (CHIP) procedures

His interventional work includes:

• AAA stent grafting
• Complex atherectomy procedures
• Selective coil embolization for life-threatening bleeding
• Over 100 complex coronary procedures using Impella support

He has also developed:

• New clinical indications for Impella in cardiomyopathy and heart failure
• A double cutting balloon aortic valvuloplasty technique for high-risk surgical patients

Clinical Philosophy

Dr. Adiraju is known for combining deep clinical expertise with continuous innovation and a focus on cost-effective, outcome-driven care. His work consistently emphasizes:

• Root-cause treatment over symptom suppression
• System-wide physiological understanding over organ-specific silos
• Personalized care based on autonomic function

Relevance to Autonomic Health

Dr. Adiraju’s decades of work in dysautonomia form the clinical backbone of Autonomic Health’s platform:

• Established autonomic testing and treatment protocols used in clinical settings
• Contributed to the FDA-approved autonomic testing methodology used across 700+ clinics and 1M+ patients
• Demonstrated >2x improvement in patient quality of life across multiple conditions

His work enables Autonomic Health to bring clinically validated autonomic medicine into mainstream care through AI and wearables, positioning the company as the nervous-system layer of modern healthcare.